Article content
Chinese scientists announced that a Japanese flu drug is equally effective in fighting coronavirus symptoms. The Czechs, in turn, have temporarily allowed the use of the experimental drug. Who will they test it on?
Permission to use the experimental drug
The Czech Ministry of Health on Tuesday temporarily approved the use of the experimental drug remdesivir for the disease COVID-19 in the Czech Republic. Prague’s General Faculty Hospital is requesting it for a critically ill patient.
Czech Prime Minister Andrej Babiš on Tuesday informed that his government has banned exporting medicines imported into the Czech Republic. This measure is intended to ensure they remain available for Czech citizens.
Čang Xin-min from the Chinese Ministry of Science said that favipiravir, as the drug is called, brought encouraging results during testing on 340 patients in Wuhan and Shenzhen, while showing a high level of safety.
Patients in Shenzhen who were given it had negative coronavirus results already after four days, whereas others without the help of favipiravir reached this on average only after eleven days.
This old Tibetan drug helps
X-rays also revealed that in up to 91 percent of people who were given favipiravir the condition of the lungs improved, while in the others, untreated this way, “it was only 62 percent.
Did you read the article to the end? Did it interest you? Then you can reward the editor’s work by liking the article on Facebook or sharing it — thank you.
